Composition and method for enabling proliferation of pluripotent stem cells
The present disclosure is directed to the development of compositions, such as extracellular matrices, and processes for using the same, that both maintain stem cells in vitro pluripotency and enable self-renewal. In this regard, it has been discovered that when pluripotent mouse and human embryonic stem cells are cultured on plates coated with recombinant laminin-10 (laminin-511) or their functional domains, in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferated and maintained their pluripotency.
1. A composition that enables self-renewal of pluripotent stem cells grown in vitro, comprising a substrate including a beta fibroblast growth factor (bFGF) and only one single laminin isoform, wherein the single laminin isoform is recombinant laminin 511 (laminin-10) and the pluripotent stem cells are mouse pluripotent embryonic stem cells, human pluripotent embryonic stem cells, or human induced pluripotent stem (iPS) cells.
2. The composition of claim 1 , wherein the composition is devoid of any differentiation inhibitors.
3. The composition of claim 1 , wherein the composition is devoid of any feeder cells.
4. The composition of claim 1 , wherein the composition is devoid of any differentiation inductors.
5. The composition of claim 1 , wherein the composition is devoid of any differentiation inhibitors, feeder cells, and differentiation inductors.
6. The composition of claim 1 , wherein the pluripotent stem cells are human iPS cells.
7. A method for maintaining the pluripotency of pluripotent stem cells in vitro, comprising:
providing a substrate including only one single laminin isoform, wherein the single laminin isoform is recombinant laminin 511(laminin-10);
placing the pluripotent stem cells on the substrate, wherein the pluripotent stem cells are mouse pluripotent embryonic stem cells, human pluripotent embryonic stem cells, or human induced pluripotent stem (iPS) cells;
exposing the pluripotent stem cells to a growth medium comprising beta fibroblast growth factor (bFGF); and
culturing the pluripotent stem cells.
8. The method of claim 7 , wherein the growth medium and the substrate are devoid of any differentiation inhibitors.
9. The method of claim 7 , wherein the composition is devoid of any feeder cells.
10. The method of claim 7 , wherein the composition is devoid of any differentiation inductors.
11. The method of claim 7 , wherein the composition is devoid of any differentiation inhibitors, feeder cells, and differentiation inductors.
12. The method of claim 7 , wherein the pluripotent stem cells are placed on the coating as a monolayer.
13. The method of claim 7 , wherein the pluripotent stem cells are placed on the coating at a density of 200 cells mm 2 or less.
14. The method of claim 7 , wherein the pluripotent stem cells are mouse pluripotent embryonic stem cells, and wherein the pluripotent stem cells are placed on the coating so that each stem cell does not contact another stem cell.
15. The method of claim 7 , wherein the pluripotent stem cells are human pluripotent embryonic stem cells.
16. The method of claim 7 , wherein the pluripotent stem cells are human iPS cells.
17. A composition that enables self-renewal of pluripotent stem cells grown in vitro, comprising a substrate consisting essentially of beta fibroblast growth factor (bFGF) and only one single laminin isoform, wherein the single laminin isoform is recombinant laminin 511(laminin-10) and the pluripotent stem cells are mouse pluripotent embryonic stem cells, human pluripotent embryonic stem cells, or human induced pluripotent stem (iPS) cells.
18. A composition that enables self-renewal of pluripotent stem cells grown in vitro, consisting of a substrate including beta fibroblast growth factor (bFGF) and a single laminin isoform which is recombinant laminin 511 (laminin-10), wherein the pluripotent stem cells are mouse pluripotent embryonic stem cells, human pluripotent embryonic stem cells, or human induced pluripotent stem (iPS) cells.